Evaluation of Hypertriglyceridemia in Critically Ill Patients With Coronavirus Disease 2019 Receiving Propofol

Objectives:. To report the prevalence of, and evaluate risk factors for, the development of hypertriglyceridemia (defined as a serum triglyceride level of > 400 mg/dL) in patients with coronavirus disease 2019 who received propofol. Design:. Single-center, retrospective, observational analysis. S...

Full description

Bibliographic Details
Published in:Critical Care Explorations
Main Authors: Mary P. Kovacevic, PharmD, BCCCP, BCPS, Kevin M. Dube, PharmD, BCCCP, BCPS, Kenneth E. Lupi, PharmD, BCCCP, BCPS, Paul M. Szumita, PharmD, FCCM, FASHP, BCCCP, BCPS, Jeremy R. DeGrado, PharmD, BCCCP, BCPS
Format: Article
Language:English
Published: Wolters Kluwer 2021-01-01
Online Access:http://journals.lww.com/10.1097/CCE.0000000000000330

Similar Items